Osborne Clarke has advised Creo Medical Group plc on the acquisition of Albyn Medical for an equity value of €24.8m. The agreement also included a performance-related…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now